Winslow Capital Management
EW icon

Winslow Capital Management’s Edwards Lifesciences EW Stock Holding History

Winslow Capital Management’s Portfolio EW Stock Details EW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-5,270,590
Closed -$487M – 64
2024
Q2 		$487M Buy
5,270,590
+211,858
+4% +$18.8M 1.76% 18
2024
Q1 		$483M Buy
+5,058,732
New +$425M 1.82% 17
2021
Q4 		– Sell
-2,305,015
Closed -$261M – 69
2021
Q3 		$261M Sell
2,305,015
-1,020,308
-31% -$116M 1.02% 40
2021
Q2 		$344M Buy
3,325,323
+298,794
+10% +$28.2M 1.34% 27
2021
Q1 		$253M Buy
3,026,529
+2,878,877
+1,950% +$243M 1.07% 37
2020
Q4 		$13.5M Buy
+147,652
New +$12.2M 0.06% 52
2019
Q1 		– Sell
-3,960
Closed -$202K – 80
2018
Q4 		$202K Sell
3,960
-4,231,350
-100% -$214M ﹤0.01% 66
2018
Q3 		$246M Sell
4,235,310
-772,515
-15% -$37.8M 1.22% 39
2018
Q2 		$243M Sell
5,007,825
-979,323
-16% -$45.7M 1.27% 37
2018
Q1 		$278M Sell
5,987,148
-269,784
-4% -$11.7M 1.51% 26
2017
Q4 		$235M Buy
6,256,932
+1,373,292
+28% +$50.4M 1.29% 34
2017
Q3 		$178M Sell
4,883,640
-1,792,353
-27% -$68.4M 0.96% 54
2017
Q2 		$263M Sell
6,675,993
-1,287,459
-16% -$47M 1.4% 28
2017
Q1 		$250M Buy
7,963,452
+59,661
+0.8% +$1.87M 1.19% 37
2016
Q4 		$247M Buy
7,903,791
+7,903,578
+3,710,600% +$256M 1.14% 41
2016
Q3 		$9K Buy
+213
New +$8.02K ﹤0.01% 147
2016
Q2 		– Sell
-7,364,178
Closed -$217M – 143
2016
Q1 		$217M Sell
7,364,178
-3,304,479
-31% -$91.2M 0.85% 58
2015
Q4 		$281M Sell
10,668,657
-1,702,935
-14% -$44.2M 1% 45
2015
Q3 		$293M Buy
+12,371,592
New +$299M 1.07% 44

Other funds holding EW

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return
Ninety One (UK)
Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return

Winslow Capital Management's EW Position: Q3 2024 in Review

Winslow Capital Management sold out of Edwards Lifesciences (EW) in Q3 2024, closing a stake of 5,270,590 shares — an estimated $487M sold.

Winslow Capital Management first reported a position in EW in Q3 2015 and held it in 19 quarters. The position peaked at $487M in Q2 2024. 1,193 funds tracked by Wall St. Rank hold EW as of Q3 2024.

  • Winslow Capital Management reported no remaining Edwards Lifesciences position as of Q3 2024 after selling out during the quarter.
  • Winslow Capital Management sold 5,270,590 Edwards Lifesciences shares in Q3 2024, an estimated $487M.
  • Winslow Capital Management first reported a position in Edwards Lifesciences in Q3 2015 and held it in 19 quarters.
  • Winslow Capital Management's Edwards Lifesciences position peaked at $487M in Q2 2024.
  • 1,193 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q3 2024.

Based on Winslow Capital Management's 13F filing for Q3 2024, filed 13 Nov 2024.